What is HC Wainwright’s Estimate for CGTX Q1 Earnings?
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Analysts at HC Wainwright issued their Q1 2026 earnings estimates for Cognition Therapeutics in a research note issued to investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju forecasts that the company will earn ($0.08) per share for the quarter. HC Wainwright has a “Buy” rating […]
